Paolo Pertile
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 10, 2021
A reply to "Who would benefit from average value-based pricing?"Rosella Levaggi, Paolo Pertile
|Jul 07, 2020
The impact of managed entry agreements on pharmaceutical prices.Simona Gamba, Paolo Pertile, Sabine Vogler
|Jun 16, 2020
Which valued-based price when patients are heterogeneous?Rosella Levaggi, Paolo Pertile
|Feb 05, 2020
Authors' Reply to Garattini and Freemantle: "Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition".Rosella Levaggi, Paolo Pertile
|Dec 03, 2019
Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition.Rosella Levaggi, Paolo Pertile
Pageof 2